Real-World Effectiveness of Systemic Agents Approved for Advanced Non-Small Cell Lung Cancer: A SEER–Medicare Analysis

OBJECTIVES. Disparity exists between patients with lung cancer enrolled in clinical trials and patients treated in the community setting. This study assessed the real-world effectiveness of cytotoxic agents that became available for the treatment of non-small cell lung cancer (NSCLC) in the last 2 d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Owonikoko, Taofeek K., Ragin, Camille, Chen, Zhengjia, Kim, Sungjin, Behera, Madhusmita, Brandes, Johann C., Saba, Nabil F., Pentz, Rebecca, Ramalingam, Suresh S., Khuri, Fadlo R.
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2013
Matèries:
Lung Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3662852/
https://ncbi.nlm.nih.gov/pubmed/23635558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0480
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars